Full-Time

Automation Process Engineer

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Compensation Overview

$96.3k - $160.5kAnnually

+ Bonus + Share-based Long Term Incentive Program

Mid, Senior

No H1B Sponsorship

Sanford, NC, USA

Work Location Assignment: On Premise; No relocation support available.

Category
Robotics and Automation Engineering
Mechanical Engineering
Required Skills
PHP
Software Testing
SQL
Requirements
  • Bachelor’s degree with at least 4 years of experience OR Master’s degree with more than 2 years of experience, OR a PhD with 0 years of experience, OR an Associate’s degree with 8 years of experience, OR a High School Diploma (or Equivalent) and 10 years of relevant experience
  • Knowledge of one or two control system platform/programming with depth of understanding
  • Prior experience with DeltaV control system is necessary
  • Relevant experience in the pharmaceutical industry
  • Broad understanding of systems architecture and operations and related components (e.g. hardware, software, network, database, S88/S95etc)
  • Experience with process controls equipment including PLCs, DCSs, HMIs, SCADA systems, SQL relational database systems, and Network Hubs including debugging skills
  • Experience with writing software test plans, user requirements, and system design documents
  • Maintenance & support of automation computing infrastructure
  • Strong history of problem-solving skills, project and task management skills
  • Ability to manage priorities and lead others under pressure
  • Strong verbal and written presentation communication skills
Responsibilities
  • Support the assigned Manufacturing Area by responding to the day-to-day automation issues that occur during batch manufacturing
  • Identify root causes to basic day-to-day problems using M1, PHP and other problem-solving methods, and implement appropriate corrective actions to prevent recurrence
  • Perform routine troubleshooting activities for automated systems
  • Automation support for continuous processes (e.g. CUB, WFI, etc), including troubleshooting, operator assistance, data reporting, investigations, etc
  • Responsible for system-wide system compliance, including alarm reporting/trending, periodic reviews, account re-certifications and user account administration
  • Perform business owned system support responsibilities for 2-3 systems and/or provides technical assistance for one or more of the following systems: DeltaV, PI, BMS, and/or FTAC
  • Support responsibilities may consist of: master data maintenance, validation support, change coordinator, user change management, performance monitoring, periodic reviews, training, project management, change controls, and release upgrades
  • Modify moderately complex to highly complex control logic that requires a degree of scientific and/or manufacturing process expertise
  • Perform automation activities for capital and non-capital projects, including project scoping and planning, generation of test protocols, execution of test protocols, final report writing for test protocols, and supervision and direction of others performing this work
  • Responsible for maintenance & support of automation computing infrastructure (software, servers, switches, controllers, HMIs, etc), incl. system health monitoring
  • Support regulatory audits through the preparation, defense and interaction with auditors in areas related to automated systems
  • Assess potential impact of changes to qualified automation systems
  • Identify and implement automation best practices to continuously improve the site automation program
  • Partner with peers at other locations and support network solutions through participation in virtual global teams to assist in establishing business systems requirements and share best practices

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its collaboration with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also the distribution of vaccines to underserved communities. The company's goal is to enhance public health by expanding its range of effective treatments and ensuring access to its products worldwide.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is